Recent evidence corroborates that CML cells outnumber normal cells, promoting proliferation, altering differentiation, and inhibiting self-renewal capacity of non-transformed progenitors via interleukin 6 34. The gene discussed is IL6; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.